Fowlicidin-1 [P7Y,Y20P]

General Information


DRACP ID  DRACP03866

Peptide Name   Fowlicidin-1 [P7Y,Y20P]

Sequence  RVKRVWYLVIRTVIAGYNLPRAIKKK

Sequence Length  26

UniProt ID  Q6QLQ5 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C148H250N44O31

Absent amino acids  CDEFHMQS

Common amino acids  KRV

Mass  358799

Pl  12.13

Basic residues  8

Acidic residues  0

Hydrophobic residues  12

Net charge  8

Boman Index  -4372

Hydrophobicity  -6.92

Aliphatic Index  127.31

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  8480

Absorbance 280nm  339.2

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Improving Cell Selectivity of Fowlicidin-1 by Swapping Residues between Pro-7 and Tyr-20

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13888

DRACP is developed by Dr.Zheng's team.